Temenos Named a Leader in Everest Group Peak Matrix® Assessments Recognition highlights Temenos’ market impact, vision and capabilities in delivering customer experience orchestration products for banks and wealth managers GRAND-LANCY, Switzerland, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been named a leader in two key Everest Group assessments. Temenos is positioned as a Leader in the and a Leader and Star Performer for the strongest year-over-year improvement in the . Everest Group’s reports evaluate the ma...
A director at Temenos AG sold 3,300 shares at 76.174CHF and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Over the past 3 years, the EU telecoms sector has had a great run – up >50%, despite modest underlying revenue/ EBITDA growth. This has almost entirely come from a deserved upwards re-rating in the multiple as the risk profile across the sector diminishes – which has been a key theme of ours in the past few years given improved regulation. So, we feel this has now largely played out.
Temenos named Best Core Banking System at Banking Tech Awards 2025 Prestigious industry award recognizes Temenos’ global banking capabilities and innovation, following earlier win in US awards GRAND-LANCY, Switzerland, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been named Best Core Banking System in the . These prestigious awards, now in their 26th year, celebrate financial institutions and technology providers that are shaping the future of the banking industry. Following on from Temenos’ recognition in the sam...
Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences New Experiences solutions, including Medidata CTMS and Medidata Clinical Data Studio, enable Caidya to enhance its white-glove service to better serve customers NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that , a leading global, mid-sized clinical research organization (CRO), has invested in additional solutions within the , including and . With Med...
National Cancer Institute Broadens Partnership with Medidata to Bring Unmatched Continuity of Medical and Clinical Data for Lead Protocol Organizations The Medidata Data Experience offering will enable the National Cancer Institute Lead Protocol Organizations to expedite the development of life-saving medicines for patients NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that and , both integral components of the , will be available to a select set of Lead Protocol O...
Temenos Named a Leader in IDC MarketScape for North America Retail Digital Banking Solutions Temenos recognized for strengths including flexible architecture, scale and reliability, as well as its ecosystem and integrations GRAND-LANCY, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been named a Leader in the (doc # US52039425, November 2025). The IDC MarketScape evaluation analyzed 10 vendors that provide self-service digital banking solutions to the North American market. The study quantitatively and...
Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies Medidata Patient Experience will accelerate CTI’s treatments for patients with oncology, metabolic, cardiovascular, central nervous system, and immune conditions NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and (CTI), a global leader in research services for advanced therapies, have expanded their 12-year relationship. The new agreement places the and its essential,...
Temenos Earns 2025 Great Place To Work Certification™ Across 15 Locations Temenos now certified in the US, India, Ecuador, Hong Kong and Taiwan in addition to 10 locations announced earlier this year GRAND-LANCY, Switzerland, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been Certified™ by To Work® in 15 locations in 2025. Following certification in , Temenos has recently been recognized as a Great Place to Work in an additional five locations: United States, India, Ecuador, Hong Kong and Taiwan. Great Place To Wor...
Medidata Unveils Next-Generation Patient Consent Innovations, Designed in Partnership with Clinicians and Patient Advocates Medidata Consent, a key part of the , expedites study start-up, reduces configuration complexity, and improves patient enrollment NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced notable advances to , its industry-proven electronic informed consent technology. Delivered through the , this modern solution reimagines patient consent in clinical trial...
UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration with Sanofi in clinical research. As part of this extension Sanofi will use the , building on the organizations’ v...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.